phosphatidylcholines has been researched along with Tuberculosis, Drug-Resistant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Han, YS; Huang, H; Jiang, TT; Li, JC; Li, ZB; Shi, LY; Wei, LL; Yi, WJ; Yu, Y | 1 |
| Baeza, I; Barrios-Payán, J; Bini, EI; Hernández-Pando, R; Marquina, B; Mata-Espinosa, D; Molina-Salinas, GM; Navarrete-Vázquez, G; Ramos-Espinosa, O | 1 |
2 other study(ies) available for phosphatidylcholines and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
The novel potential biomarkers for multidrug-resistance tuberculosis using UPLC-Q-TOF-MS.
Topics: Adult; Biomarkers; Caprylates; Chromatography, Liquid; Female; Humans; Male; Mass Spectrometry; Middle Aged; Phosphatidylcholines; Pyridones; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Xylose | 2020 |
Therapeutic efficacy of liposomes containing 4-(5-pentadecyl-1,3,4-oxadiazol-2-yl)pyridine in a murine model of progressive pulmonary tuberculosis.
Topics: Animals; Antitubercular Agents; Cholesterol; Disease Models, Animal; Isoniazid; Liposomes; Male; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Oxadiazoles; Phosphatidic Acids; Phosphatidylcholines; Pyridines; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2015 |